title: Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies.
abstract: Nociceptin/orphanin FQ (N/OFQ) regulates several biological functions via selective activation of the N/OFQ peptide (NOP) receptor. Recently knockout rats for the NOP receptor gene (NOP(-/-)) have been generated; these animals were used in the present study to investigate their emotional (open field, elevated plus maze, and forced swimming test), locomotor (drag and rotarod test), and nociceptive (plantar and formalin test) phenotypes in comparison with their NOP(+/+) littermates. In addition, N/OFQ sensitivity has been assessed in electrically stimulated vas deferens tissues taken from NOP(+/+) and NOP(-/-) rats. In the elevated plus maze and forced swimming tests NOP(-/-) rats showed anxiety- and anti-depressant-like phenotype, respectively. No differences were found in the open field test. NOP(-/-) rats outperformed their NOP(+/+) littermates in two motor behaviour assays. Genetic ablation of the NOP receptor gene produced a statistically significant increase in nociceptive behaviour of the mutant rats in the formalin test. Finally, in the electrically stimulated rat vas deferens taken from NOP(+/+) tissues, N/OFQ inhibited in a concentration-dependent manner the electrically induced twitches while the peptide was inactive in tissues taken from NOP(-/-) animals. These results, in line with previous findings obtained with selective NOP receptor antagonists in mice and rats and with mouse knockout studies, clearly indicate that endogenous N/OFQ-NOP receptor signalling plays an important role in controlling anxiety- and mood-related behaviours, exercise-driven locomotor activity and nociception. These observations are relevant for defining the therapeutic indications (and contraindications) of NOP receptor antagonists.
authors.affiliation: Department of Experimental and Clinical Medicine, University of Ferrara, Ferrara, Italy.
authors.forename: Anna
authors.initials: A
authors.lastname: Rizzi
authors.forename: Stefano
authors.initials: S
authors.lastname: Molinari
authors.forename: Matteo
authors.initials: M
authors.lastname: Marti
authors.forename: Giuliano
authors.initials: G
authors.lastname: Marzola
authors.forename: Girolamo
authors.initials: G
authors.lastname: Calo'
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001007:Anxiety / Q000235:genetics*; D001522:Behavior, Animal / Q000502:physiology*; D003863:Depression / Q000235:genetics*; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D008297:Male; D009043:Motor Activity / Q000235:genetics*; D018847:Opioid Peptides / Q000494:pharmacology; D051381:Rats; D055647:Rats, Transgenic; D011957:Receptors, Opioid / Q000235:genetics*; D045442:Rotarod Performance Test; D014649:Vas Deferens / Q000187:drug effects / Q000502:physiology; D000094942:Nociceptin Receptor; D000097629:Nociceptin
chemical_list: D018847:Opioid Peptides; D011957:Receptors, Opioid; D000094942:Nociceptin Receptor; D000097629:Nociceptin; C000722285:Oprl1 protein, rat